INSIGHTS & POINT OF VIEW Sage Thoughts
News The latest from Sage
PATIENTS & CARE PARTNERS Putting patients and their families first
We are rethinking care and how it is delivered to help patients and families impacted by brain health disorders.
HEALTHCARE PROVIDERS It’s an exciting time in neuroscience
At Sage, our goal is to originate meaningfully differentiated drug candidates. We aim to discover new pathways to brain health by making medicines that matter so patients can get better, sooner.
CLINICAL TRIALS A distinct approach to neuroscience drug development
Sage is committed to developing new medicines to treat life-altering brain health disorders.PIPELINE Advancing a leading brain health portfolio
We seek to make a positive impact on the unmet treatment needs of patients by advancing product candidates from a robust development pipeline of potential brain health disorder treatments.Compound
Partners
Indications
Preclinical
Phase 1
Phase 2
Phase 3
Registration
Marketed
Depression Franchise
ZULRESSO
(brexanolone) CIV injection
(brexanolone) CIV injection
Postpartum Depression
100
Zuranolone
(SAGE-217)
(SAGE-217)
Major Depressive Disorder
72
Postpartum Depression*
58
Treatment Resistant
40
Generalized Anxiety Disorder
40
Bipolar Depression
40
NEUROLOGY FRANCHISE
SAGE-324
Essential Tremor
40
Epileptiform Disorders
19
Parkinson's Disease
19
SAGE-689
Acute GABA Hypofunction
19
NEUROPSYCHIATRY FRANCHISE
SAGE-718
Huntington's Disease Cognitive Dysfunction
40
Parkinson's Disease Cognitive Dysfunction
40
Alzheimer's Disease Mild Cognitive Impairment and Mild Dementia
40
ADDITIONAL CLINICAL PROGRAMS
SAGE-421
NMDA Hypofunction
3
GABA Hypofunction
3
*Rolling submission of NDA in MDD initiated with FDA, which we expect to complete in 2H22
- - - indicates trials in the planning or evaluation stage
Please refer to the U.S. Prescription Information for brexanolone
Safety and efficacy for investigational uses or compounds have not been established. There is no guarantee that the outcome of these studies will be positive or result in the approval by a Health Authority.
CAREERS Rethinking brain health disorders to make life better for patients and their families
Sage is a place where unconventional thinking to solve problems with new ideas is welcome - and where unconventional thinkers can imagine what's possible and do big.
We have recently updated our Privacy Policy to include information regarding the cookies we collect. By continuing to use this website you agree to our
Privacy Policy
and
Terms of Use
.